To see this page, please, enable javaScript and styleSheets on your browser: Tools -> Internet Options ...
Reload !
Gene SGOL1TABLE OF CONTENTS / OPEN CLOSE ALL PARAGRAPHS
Summary back to top
Compact gene diagram back to top
103 supporting clones for gene SGOL1 back to top
cDNA accession
Links to the sequence
Tissue

most 5' clones
in red
Match
mRNA
From bp
to bp
in mRNA
From bp
to bp
in accs.
Clone encodes
complete protein
(with AA variation)
Features Anomalies
detected by
AceView
Accession
match over
(% length)
Base differences
relative to genome
(% identity)
BX494477 Liver .a 1 to 678 6 to 683       683/683
(100 %)
5 diff
(99.3 %id)
DB163747 thymus .a 1 to 569 2 to 570   tiling clone, capped   569/569
(100 %)
0 diff
(100 %id)
AK308095   .a 11 to 1615 1 to 1604       1604/1604
(100 %)
2 diff
(99.9 %id)
DA755289   .a 12 to 564 2 to 554   capped   553/553
(100 %)
0 diff
(100 %id)
BJ991662 hepatoblastoma .a 17 to 468 1 to 452       452/452
(100 %)
1 diff
(99.8 %id)
BP365105 lung .a 22 to 598 1 to 576       576/583
(98 %)
10 diff
(98.3 %id)
BU595135 mixed (pool of 40 RNAs) .a 23 to 765 1 to 739       739/853
(86 %)
24 diff
(97.2 %id)
BF209886 bone marrow, from chronic myelogenous leukemia .a 25 to 630 1 to 611       611/623
(98 %)
19 diff
(97.0 %id)
BP233364 coronary artery .a 27 to 614 1 to 588       588/588
(100 %)
1 diff
(99.9 %id)
DB019350 esophageal, tumor tissue .a 27 to 600 2 to 574   capped   573/574
(99 %)
3 diff
(99.5 %id)
CN392951 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .a 50 to 784 1 to 737       737/737
(100 %)
4 diff
(99.5 %id)
AB193060   .a 105 to 2073 1 to 1969 exact tiling clone,   1969/1969
(100 %)
0 diff
(100 %id)
BG530826 embryonal carcinoma, testis .b 1 to 761 3 to 762   tiling clone,   762/762
(100 %)
16 diff
(98.0 %id)
AB187578   .b 15 to 2350 1 to 2336 exact tiling clone, AAA Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) 2336/2336
(100 %)
1 diff
(100.0 %id)
NM_001012410.2   .b 15 to 2350 1 to 2336 exact RefSeq, AAA Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) 2336/2336
(100 %)
1 diff
(100.0 %id)
BM463207 embryonal carcinoma, cell line, testis .b 50 to 1034 1 to 997       997/1002
(99 %)
46 diff
(95.5 %id)
AB193061   .b 79 to 1936 1 to 1858 exact     1858/1858
(100 %)
0 diff
(100 %id)
BP284276 bone marrow .b 218 to 798 1 to 582       582/582
(100 %)
2 diff
(99.7 %id)
BE548408 cervical carcinoma cell line, cervix .b 297 to 960 79 to 737   available from MGC,   659/1097
(60 %)
39 diff
(96.5 %id)
AA631163 colon, colon tumor RER+ .b 457 to 1022 570 to 5       566/570
(99 %)
0 diff
(100 %id)
BY996848   .b 581 to 1221 10 to 650       641/650
(98 %)
6 diff
(99.1 %id)
BQ310278 breast .b 964 to 1477 526 to 15       512/526
(97 %)
6 diff
(98.9 %id)
BF035618 adenocarcinoma, ovary .b 989 to 1593 1 to 605   available from MGC,   605/605
(100 %)
1 diff
(99.9 %id)
BY996230   .b 1210 to 1923 6 to 719       714/719
(99 %)
5 diff
(99.4 %id)
AB190994   .c 1 to 1827 1 to 1827 exact tiling clone, AAA   1827/1827
(100 %)
1 diff
(100.0 %id)
BC032696 Breast, mammary adenocarcinoma. .c 936 to 2263 12 to 1339   tiling clone, available from MGC, AAA   1328/1328
(100 %)
1 diff
(100.0 %id)
BU195471 eye, retinoblastoma .c 1264 to 2153 1 to 897   tiling clone,   897/901
(99 %)
13 diff
(98.6 %id)
AB187577   .d 1 to 1937 1 to 1937 exact tiling clone, AAA   1937/1937
(100 %)
2 diff
(99.9 %id)
NM_001012409.1   .d 1 to 1937 1 to 1937 exact RefSeq, AAA   1937/1937
(100 %)
2 diff
(99.9 %id)
AB451340   .d 141 to 1722 1 to 1582       1582/1584
(99 %)
1 diff
(100.0 %id)
AB451489   .d 141 to 1721 1 to 1581       1581/1581
(100 %)
0 diff
(100 %id)
BC001339 Cervix, carcinoma .d 210 to 1937 11 to 1738   available from MGC, AAA   1728/1728
(100 %)
5 diff
(99.8 %id)
AF308299 breast .d 887 to 1934 1 to 1048   tiling clone,   1048/1049
(99 %)
1 diff
(100.0 %id)
BC039605 Ovary, adenocarcinoma .d 954 to 1937 1 to 984   available from MGC, AAA   984/984
(100 %)
1 diff
(99.9 %id)
TI_59392485   .d 1046 to 1845 47 to 846       800/801
(99 %)
6 diff
(99.3 %id)
BM014461 breast, mammary adenocarcinoma, cell line .d 1047 to 1845 1 to 799   available from MGC,   799/800
(99 %)
6 diff
(99.3 %id)
AW968705   .d 1281 to 1834 1 to 552       552/569
(97 %)
14 diff
(97.6 %id)
AI983275 pooled germ cell tumors .d 1295 to 1736 442 to 1       442/442
(100 %)
1 diff
(99.8 %id)
AA481123 germinal center B cell .d 1344 to 1630 1 to 286   fully sequenced,   286/286
(100 %)
1 diff
(99.7 %id)
AA481066 germinal center B cell .d 1582 to 1932 382 to 33   fully sequenced, AAA   350/350
(100 %)
0 diff
(100 %id)
AB193062   .e 1 to 1213 1 to 1213 exact tiling clone,   1213/1213
(100 %)
0 diff
(100 %id)
BG394361 eye, retinoblastoma .f 1 to 680 8 to 688       688/1037
(66 %)
9 diff
(99.2 %id)
BG394433 eye, retinoblastoma .f 1 to 810 8 to 811   tiling clone,   811/951
(85 %)
25 diff
(97.4 %id)
BF247154 hypernephroma, Kidney .f 1 to 671 3 to 661       662/747
(88 %)
44 diff
(94.2 %id)
DA008077   .f 1 to 543 2 to 544   capped   543/543
(100 %)
1 diff
(99.9 %id)
AB187580   .f 15 to 1594 1 to 1580 exact tiling clone, AAA Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) 1580/1580
(100 %)
1 diff
(100.0 %id)
NM_001012412.2   .f 15 to 1594 1 to 1580 exact RefSeq, AAA Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) 1580/1580
(100 %)
1 diff
(100.0 %id)
BU662606 blood .f 21 to 644 9 to 632       624/632
(98 %)
6 diff
(99.1 %id)
AB193063   .f 79 to 1180 1 to 1102 exact     1102/1102
(100 %)
0 diff
(100 %id)
CN392949 embryonic stem cells, cell lines H1, H7, andH9 .f 160 to 890 1 to 732       732/743
(98 %)
5 diff
(99.4 %id)
AB193065   .g 1 to 1162 1 to 1162 exact tiling clone,   1162/1162
(100 %)
0 diff
(100 %id)
AB187582   .h 1 to 1529 1 to 1529 exact tiling clone, AAA Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) 1529/1529
(100 %)
1 diff
(100.0 %id)
BC017867 Lung, mucoepidermoid carcinoma .h 1 to 1529 1 to 1529 exact available from MGC, AAA Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) 1529/1529
(100 %)
1 diff
(100.0 %id)
NM_138484.2   .h 1 to 1529 1 to 1529 exact RefSeq, AAA Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) 1529/1529
(100 %)
1 diff
(100.0 %id)
AB193066   .h 65 to 1115 1 to 1051 exact tiling clone,   1051/1051
(100 %)
0 diff
(100 %id)
CX868303 embryonic stem .i 1 to 651 1 to 651   tiling clone,   651/651
(100 %)
0 diff
(100 %id)
AB193059   .i 38 to 1112 1 to 1075 exact tiling clone,   1075/1075
(100 %)
1 diff
(100.0 %id)
CX868233 embryonic stem .i 762 to 1265 529 to 26   AAA   504/504
(100 %)
3 diff
(99.5 %id)
AK024292   .i 1101 to 3312 1 to 2212   tiling clone, available from FLJ,   2212/2212
(100 %)
18 diff
(99.2 %id)
AU132400   .i 1102 to 1816 2 to 715   capped   714/718
(99 %)
11 diff
(98.5 %id)
BI089107 cervix .i 1807 to 2447 1 to 641   tiling clone,   641/641
(100 %)
1 diff
(99.9 %id)
BU656429 blood .i 2253 to 2664 425 to 14     Submitted on the opposite strand 412/425
(96 %)
0 diff
(100 %id)
CN360789 embryonic stem cells, DMSO-treated H9 cellline .i 2437 to 2994 1 to 558   tiling clone,   558/558
(100 %)
4 diff
(99.3 %id)
AU153922   .i 2840 to 3312 470 to 1       470/470
(100 %)
15 diff
(96.9 %id)
AB187579   .j 1 to 1181 1 to 1181 exact tiling clone, AAA   1181/1181
(100 %)
2 diff
(99.9 %id)
NM_001012411.1   .j 1 to 1181 1 to 1181 exact RefSeq, AAA   1181/1181
(100 %)
2 diff
(99.9 %id)
AB193058   .j 65 to 1028 1 to 964 exact tiling clone,   964/964
(100 %)
1 diff
(99.9 %id)
BX648516 human endometrium carcinoma cell line .k 1 to 2259 3 to 2261 exact tiling clone, available from DKFZ, AAA   2261/2261
(100 %)
3 diff
(99.9 %id)
BG720631 testis .k 9 to 648 1 to 639       639/639
(100 %)
2 diff
(99.7 %id)
AB193056   .k 79 to 1102 1 to 1024 exact     1024/1024
(100 %)
1 diff
(100.0 %id)
CX164712 human embryonic stem cells differentiated toan early endodermal cell type .k 638 to 1420 1 to 783   tiling clone,   783/783
(100 %)
4 diff
(99.5 %id)
AI051509   .k 951 to 1258 309 to 2       308/309
(99 %)
0 diff
(100 %id)
R91350 liver and spleen .k 1346 to 1757 1 to 418       418/432
(96 %)
14 diff
(96.8 %id)
AW972446   .k 1511 to 1861 59 to 409       351/434
(80 %)
11 diff
(97.5 %id)
AW972643   .k 1511 to 1858 114 to 461       348/473
(73 %)
2 diff
(99.6 %id)
BF701513 brain, primitive neuroectoderm .k 1520 to 2138 1 to 606       606/873
(69 %)
16 diff
(98.2 %id)
AA514803 Prostate .k 1529 to 1743 1 to 215       215/215
(100 %)
0 diff
(100 %id)
BF668922 brain, primitive neuroectoderm .k 1584 to 1935 299 to 646       348/646
(53 %)
6 diff
(99.1 %id)
BF983603 duodenal adenocarcinoma, cell line, small intestine .k 1624 to 1984 1 to 361       361/361
(100 %)
0 diff
(100 %id)
FN090287 breast carcinoma .k 2133 to 2226 1 to 92       92/92
(100 %)
5 diff
(94.6 %id)
BX375095 Neuroblastoma Cot 25-normalized .l 1 to 1140 1 to 1125 K23X E24X L96X K100X tiling clone,   1125/1125
(100 %)
26 diff
(97.7 %id)
BP284700 bone marrow .l 6 to 601 1 to 596   tiling clone,   596/596
(100 %)
0 diff
(100 %id)
BG527250 lung, mucoepidermoid carcinoma .l 8 to 630 1 to 627       627/809
(77 %)
16 diff
(98.1 %id)
BU164324 embryonal carcinoma, cell line, testis .l 8 to 888 1 to 890       890/891
(99 %)
11 diff
(98.8 %id)
AB187581   .l 9 to 1138 1 to 1130 exact tiling clone, AAA   1130/1130
(100 %)
2 diff
(99.9 %id)
NM_001012413.1   .l 9 to 1138 1 to 1130 exact RefSeq, AAA   1130/1130
(100 %)
2 diff
(99.9 %id)
AB193057   .l 73 to 985 1 to 913 exact tiling clone,   913/913
(100 %)
1 diff
(99.9 %id)
BX350945 Neuroblastoma Cot 25-normalized .l 1272 to 2145 873 to 1   tiling clone,   873/875
(99 %)
14 diff
(98.4 %id)
AB193064   .m 1 to 931 1 to 931 exact tiling clone,   931/931
(100 %)
0 diff
(100 %id)
BM147491 leukopheresis .m 164 to 692 1 to 529       529/529
(100 %)
1 diff
(99.9 %id)
BM149339 leukopheresis .m 164 to 696 1 to 533       533/533
(100 %)
6 diff
(98.9 %id)
BM148884 leukopheresis .m 164 to 708 1 to 546       546/547
(99 %)
2 diff
(99.7 %id)
BQ308133 breast .n 70 to 548 151 to 623 R99C S121C H150T N151M A152L ... tiling clone,   632/678
(93 %)
66 diff
(90.3 %id)
CN392950 embryonic stem cells, DMSO-treated H9 cellline .o 1 to 649 4 to 653   tiling clone,   653/653
(100 %)
6 diff
(99.1 %id)
BP353118   .o 15 to 607 1 to 593       593/593
(100 %)
0 diff
(100 %id)
CX757405 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass .o 17 to 685 1 to 668 M122N D123G N125H F134L V135* tiling clone, Submitted on the opposite strand 668/842
(79 %)
5 diff
(99.5 %id)
BP245550 Kidney .o 25 to 605 1 to 581       581/581
(100 %)
1 diff
(99.9 %id)
BM457156 embryonal carcinoma, cell line, testis .p 1 to 899 1 to 911 S82V M83* tiling clone,   911/1021
(89 %)
23 diff
(97.8 %id)
DB446702 testis .q 1 to 425 1 to 426 P12A R13T D14* tiling clone,   426/426
(100 %)
5 diff
(98.9 %id)
CA455537 mixed (pool of 40 RNAs) .q 85 to 418 1 to 334   tiling clone, AAA   334/334
(100 %)
2 diff
(99.5 %id)
AW977697   Gene SGOL1, variant not shown         This clone was ignored    
CD688716 normal nasopharynx Gene SGOL1, variant not shown         Suspected internal deletion, this clone was ignored    
N59527 liver and spleen Gene SGOL1, variant not shown         This clone was ignored    
N78267 liver and spleen Gene SGOL1, variant not shown         This clone was ignored    
AA761635 germinal center B cell Gene SGOL1, variant not shown         Submitted on the opposite strand    
AA827715 germinal center B cell Gene SGOL1, variant not shown         Submitted on the opposite strand    
AI248925 liver and spleen Gene SGOL1, variant not shown         Suspected internal deletion, this clone was ignored    
CA432045 cell lines, Enchondroma Gene SGOL1, variant not shown       AAA This clone was ignored    
? Gene Summary Gene on genome mRNA:.a, .b, .c, .d, .e, .f, .g, .h, .i, .j, .k, .l, .m, .n, .o, .p, .q Alternative mRNAs features, proteins, introns, exons, sequences Expression Tissue Function, regulation, related genes DCI